Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP836902.RAdZnF6cqczq_3SIWe2S1ZU2zwmL8BCXbUscs4qWPY7Po130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP836902.RAdZnF6cqczq_3SIWe2S1ZU2zwmL8BCXbUscs4qWPY7Po130_assertion type Assertion NP836902.RAdZnF6cqczq_3SIWe2S1ZU2zwmL8BCXbUscs4qWPY7Po130_head.
- NP836902.RAdZnF6cqczq_3SIWe2S1ZU2zwmL8BCXbUscs4qWPY7Po130_assertion description "[The association of interleukin-1beta (IL-1B) -511C > T and IL-1 receptor antagonist (IL-1RN) VNTR, transforming growth factor-beta (TGF-B1) +28C > T and interferon-gamma (IFN-G) + 874T>A polymorphisms with bladder cancer (CaB) susceptibility and risk of recurrence in Bacillus Calmette-Gu�rin (BCG)-treated patients was analyzed in 287 controls and 213 CaB patients (73 BCG treated).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836902.RAdZnF6cqczq_3SIWe2S1ZU2zwmL8BCXbUscs4qWPY7Po130_provenance.
- NP836902.RAdZnF6cqczq_3SIWe2S1ZU2zwmL8BCXbUscs4qWPY7Po130_assertion evidence source_evidence_literature NP836902.RAdZnF6cqczq_3SIWe2S1ZU2zwmL8BCXbUscs4qWPY7Po130_provenance.
- NP836902.RAdZnF6cqczq_3SIWe2S1ZU2zwmL8BCXbUscs4qWPY7Po130_assertion SIO_000772 19489682 NP836902.RAdZnF6cqczq_3SIWe2S1ZU2zwmL8BCXbUscs4qWPY7Po130_provenance.
- NP836902.RAdZnF6cqczq_3SIWe2S1ZU2zwmL8BCXbUscs4qWPY7Po130_assertion wasDerivedFrom befree-20140225 NP836902.RAdZnF6cqczq_3SIWe2S1ZU2zwmL8BCXbUscs4qWPY7Po130_provenance.
- NP836902.RAdZnF6cqczq_3SIWe2S1ZU2zwmL8BCXbUscs4qWPY7Po130_assertion wasGeneratedBy ECO_0000203 NP836902.RAdZnF6cqczq_3SIWe2S1ZU2zwmL8BCXbUscs4qWPY7Po130_provenance.